 Paul Buehler
Concepts (485)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 66 | 2026 | 376 | 10.560 |
Why?
| | Anemia, Sickle Cell | 21 | 2026 | 309 | 4.500 |
Why?
| | Haptoglobins | 25 | 2026 | 66 | 4.300 |
Why?
| | Hemopexin | 12 | 2025 | 38 | 3.530 |
Why?
| | Erythrocytes | 27 | 2026 | 757 | 3.160 |
Why?
| | Oxygen | 27 | 2025 | 1003 | 3.140 |
Why?
| | Hemolysis | 23 | 2026 | 244 | 2.760 |
Why?
| | Blood Substitutes | 15 | 2024 | 28 | 2.650 |
Why?
| | Erythrocyte Transfusion | 9 | 2024 | 228 | 2.010 |
Why?
| | Thrombin | 7 | 2023 | 171 | 1.830 |
Why?
| | Extracellular Vesicles | 3 | 2023 | 170 | 1.810 |
Why?
| | Heme | 15 | 2025 | 89 | 1.770 |
Why?
| | Guinea Pigs | 23 | 2024 | 164 | 1.710 |
Why?
| | Cation Transport Proteins | 4 | 2026 | 118 | 1.610 |
Why?
| | Iron | 18 | 2025 | 357 | 1.550 |
Why?
| | Fibrinolysin | 4 | 2022 | 19 | 1.460 |
Why?
| | Transferrin | 5 | 2025 | 50 | 1.370 |
Why?
| | Homeostasis | 3 | 2020 | 644 | 1.370 |
Why?
| | Kidney | 13 | 2020 | 1496 | 1.310 |
Why?
| | Oxidation-Reduction | 26 | 2020 | 1099 | 1.210 |
Why?
| | Animals | 85 | 2026 | 38331 | 1.140 |
Why?
| | Complement C1 Inhibitor Protein | 4 | 2023 | 11 | 1.130 |
Why?
| | Hypertension, Pulmonary | 8 | 2026 | 1979 | 1.050 |
Why?
| | Blood Preservation | 10 | 2023 | 353 | 1.010 |
Why?
| | Blood Transfusion | 6 | 2021 | 405 | 0.990 |
Why?
| | Oxyhemoglobins | 5 | 2021 | 28 | 0.940 |
Why?
| | Diagnostic Equipment | 1 | 2025 | 5 | 0.930 |
Why?
| | Thrombosis | 4 | 2022 | 393 | 0.920 |
Why?
| | Oximetry | 3 | 2021 | 128 | 0.850 |
Why?
| | Hydrogen Peroxide | 12 | 2021 | 340 | 0.840 |
Why?
| | Hypoxia | 7 | 2026 | 1201 | 0.820 |
Why?
| | Electron Spin Resonance Spectroscopy | 7 | 2025 | 98 | 0.810 |
Why?
| | Thrombomodulin | 3 | 2022 | 15 | 0.800 |
Why?
| | Thrombotic Microangiopathies | 2 | 2020 | 20 | 0.780 |
Why?
| | Apoproteins | 3 | 2020 | 15 | 0.760 |
Why?
| | Hypercholesterolemia | 1 | 2023 | 93 | 0.760 |
Why?
| | Oxidative Stress | 16 | 2025 | 1379 | 0.720 |
Why?
| | Drug Design | 3 | 2021 | 175 | 0.700 |
Why?
| | Ascorbic Acid | 6 | 2019 | 181 | 0.690 |
Why?
| | Shock, Hemorrhagic | 1 | 2023 | 202 | 0.670 |
Why?
| | Nitric Oxide | 11 | 2021 | 907 | 0.660 |
Why?
| | Antibodies, Bispecific | 1 | 2021 | 64 | 0.660 |
Why?
| | Humans | 97 | 2026 | 144848 | 0.660 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 14 | 0.650 |
Why?
| | Hemolytic-Uremic Syndrome | 1 | 2020 | 15 | 0.650 |
Why?
| | Hematologic Diseases | 2 | 2018 | 68 | 0.650 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 7 | 2021 | 69 | 0.630 |
Why?
| | Polymers | 6 | 2024 | 500 | 0.620 |
Why?
| | Recombinant Proteins | 4 | 2021 | 1358 | 0.610 |
Why?
| | Lipids | 3 | 2023 | 701 | 0.610 |
Why?
| | Hemophilia A | 1 | 2021 | 146 | 0.600 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 190 | 0.570 |
Why?
| | Vascular Diseases | 3 | 2024 | 251 | 0.560 |
Why?
| | Receptors, Cell Surface | 7 | 2021 | 380 | 0.550 |
Why?
| | Transfusion Reaction | 3 | 2020 | 62 | 0.540 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4605 | 0.530 |
Why?
| | beta-Thalassemia | 3 | 2025 | 40 | 0.520 |
Why?
| | Lipoproteins | 1 | 2018 | 163 | 0.520 |
Why?
| | Antigens, CD | 7 | 2021 | 564 | 0.510 |
Why?
| | Biomarkers | 6 | 2020 | 4279 | 0.500 |
Why?
| | Inflammation | 5 | 2026 | 2911 | 0.490 |
Why?
| | Lung | 7 | 2025 | 4190 | 0.480 |
Why?
| | Lipid Peroxidation | 8 | 2018 | 164 | 0.470 |
Why?
| | Acute Kidney Injury | 4 | 2018 | 851 | 0.460 |
Why?
| | Hemochromatosis | 1 | 2015 | 8 | 0.450 |
Why?
| | beta-Globins | 1 | 2015 | 8 | 0.450 |
Why?
| | Spleen | 4 | 2025 | 518 | 0.440 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2025 | 34 | 0.430 |
Why?
| | Glutaral | 3 | 2012 | 15 | 0.410 |
Why?
| | Exercise Tolerance | 3 | 2025 | 288 | 0.400 |
Why?
| | Rats, Sprague-Dawley | 10 | 2024 | 2538 | 0.400 |
Why?
| | Mice | 19 | 2026 | 18549 | 0.400 |
Why?
| | Gene Deletion | 1 | 2015 | 388 | 0.390 |
Why?
| | Rats | 15 | 2024 | 5632 | 0.390 |
Why?
| | Peroxidases | 3 | 2015 | 29 | 0.380 |
Why?
| | Male | 44 | 2026 | 72182 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3861 | 0.380 |
Why?
| | Polyethylene Glycols | 5 | 2024 | 646 | 0.370 |
Why?
| | Models, Animal | 4 | 2020 | 394 | 0.370 |
Why?
| | Receptors, Scavenger | 6 | 2021 | 22 | 0.370 |
Why?
| | Blood Coagulation | 4 | 2022 | 272 | 0.360 |
Why?
| | Macrophages | 6 | 2023 | 1532 | 0.360 |
Why?
| | Cattle | 9 | 2022 | 1006 | 0.340 |
Why?
| | Sodium Nitrite | 1 | 2011 | 39 | 0.330 |
Why?
| | Protein Binding | 9 | 2026 | 2276 | 0.330 |
Why?
| | Central Nervous System Diseases | 1 | 2011 | 75 | 0.320 |
Why?
| | Drug Carriers | 2 | 2008 | 130 | 0.320 |
Why?
| | Biopolymers | 1 | 2010 | 34 | 0.310 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2011 | 300 | 0.310 |
Why?
| | Heme Oxygenase (Decyclizing) | 6 | 2013 | 22 | 0.310 |
Why?
| | Heme Oxygenase-1 | 8 | 2025 | 77 | 0.310 |
Why?
| | Biological Transport | 2 | 2021 | 412 | 0.300 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2015 | 144 | 0.300 |
Why?
| | Biological Products | 3 | 2022 | 252 | 0.300 |
Why?
| | Molecular Weight | 6 | 2024 | 325 | 0.300 |
Why?
| | Lung Diseases | 2 | 2015 | 796 | 0.290 |
Why?
| | Erythrocyte Deformability | 2 | 2023 | 23 | 0.290 |
Why?
| | Central Nervous System | 1 | 2011 | 282 | 0.290 |
Why?
| | Hemodynamics | 4 | 2023 | 1117 | 0.290 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1136 | 0.280 |
Why?
| | Liver | 4 | 2025 | 1853 | 0.280 |
Why?
| | Amino Acids | 4 | 2021 | 520 | 0.280 |
Why?
| | Microvessels | 2 | 2020 | 98 | 0.270 |
Why?
| | Erythrocyte Indices | 2 | 2019 | 31 | 0.270 |
Why?
| | Proteome | 3 | 2025 | 517 | 0.260 |
Why?
| | Plasma Exchange | 1 | 2007 | 18 | 0.260 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 69 | 0.260 |
Why?
| | Endothelial Cells | 4 | 2024 | 874 | 0.260 |
Why?
| | Erythropoiesis | 2 | 2019 | 57 | 0.260 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2019 | 2037 | 0.260 |
Why?
| | Uric Acid | 1 | 2008 | 166 | 0.250 |
Why?
| | Proteomics | 7 | 2025 | 1196 | 0.250 |
Why?
| | Signal Transduction | 4 | 2019 | 5277 | 0.250 |
Why?
| | Extracorporeal Circulation | 1 | 2026 | 15 | 0.240 |
Why?
| | Myocardium | 4 | 2019 | 949 | 0.240 |
Why?
| | Blood Circulation | 1 | 2005 | 44 | 0.230 |
Why?
| | Methemoglobin | 4 | 2021 | 24 | 0.230 |
Why?
| | Vascular Remodeling | 2 | 2019 | 204 | 0.230 |
Why?
| | Circular Dichroism | 2 | 2021 | 150 | 0.220 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 583 | 0.220 |
Why?
| | Chromatography, Gel | 5 | 2010 | 129 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Antioxidants | 1 | 2008 | 581 | 0.210 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 6067 | 0.210 |
Why?
| | Riboflavin | 1 | 2024 | 15 | 0.210 |
Why?
| | Vasoconstriction | 4 | 2020 | 218 | 0.210 |
Why?
| | Vascular Resistance | 2 | 2016 | 366 | 0.210 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 54 | 0.210 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2023 | 24 | 0.200 |
Why?
| | Aspirin | 2 | 2006 | 389 | 0.200 |
Why?
| | Nails | 1 | 2023 | 13 | 0.200 |
Why?
| | Equipment Design | 1 | 2025 | 534 | 0.200 |
Why?
| | Hemoglobin A | 4 | 2006 | 21 | 0.200 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 140 | 0.200 |
Why?
| | Blood Pressure | 6 | 2018 | 1752 | 0.200 |
Why?
| | Muscle, Skeletal | 3 | 2025 | 1810 | 0.200 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 968 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.190 |
Why?
| | Perfusion | 1 | 2024 | 247 | 0.190 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 248 | 0.190 |
Why?
| | Protein Engineering | 2 | 2018 | 124 | 0.180 |
Why?
| | Species Specificity | 2 | 2020 | 576 | 0.180 |
Why?
| | Radiation Injuries | 1 | 2023 | 149 | 0.180 |
Why?
| | Superoxides | 1 | 2022 | 207 | 0.180 |
Why?
| | Receptor, PAR-1 | 1 | 2022 | 16 | 0.180 |
Why?
| | Receptors, Thrombin | 1 | 2022 | 15 | 0.180 |
Why?
| | Mycoplasma hyorhinis | 1 | 2021 | 1 | 0.180 |
Why?
| | Methemoglobinemia | 2 | 2015 | 13 | 0.180 |
Why?
| | Intestinal Absorption | 1 | 2002 | 101 | 0.180 |
Why?
| | Fibrinolysis | 2 | 2022 | 162 | 0.170 |
Why?
| | Magnetics | 1 | 2021 | 48 | 0.170 |
Why?
| | Blood Coagulation Tests | 1 | 2021 | 71 | 0.170 |
Why?
| | Ultraviolet Rays | 1 | 2024 | 388 | 0.170 |
Why?
| | Cell Line | 6 | 2015 | 2911 | 0.170 |
Why?
| | Methemalbumin | 1 | 2021 | 1 | 0.170 |
Why?
| | Photoelectron Spectroscopy | 1 | 2021 | 6 | 0.170 |
Why?
| | Factor VIII | 1 | 2021 | 104 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.170 |
Why?
| | Tranexamic Acid | 1 | 2021 | 53 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.170 |
Why?
| | Free Radicals | 4 | 2015 | 107 | 0.170 |
Why?
| | Models, Biological | 4 | 2018 | 1837 | 0.170 |
Why?
| | Antifibrinolytic Agents | 1 | 2021 | 62 | 0.170 |
Why?
| | Pulmonary Artery | 3 | 2019 | 1136 | 0.170 |
Why?
| | Polymerization | 3 | 2023 | 131 | 0.160 |
Why?
| | Hypertension | 3 | 2020 | 1241 | 0.160 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 31 | 0.160 |
Why?
| | Beta vulgaris | 1 | 2020 | 14 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2002 | 170 | 0.160 |
Why?
| | CD40 Antigens | 1 | 2021 | 90 | 0.160 |
Why?
| | Lung Transplantation | 1 | 2024 | 336 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 83 | 0.160 |
Why?
| | Subarachnoid Space | 1 | 2019 | 9 | 0.160 |
Why?
| | Vasospasm, Intracranial | 1 | 2019 | 19 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2020 | 76 | 0.150 |
Why?
| | Protein Unfolding | 1 | 2019 | 33 | 0.150 |
Why?
| | Biotechnology | 1 | 2019 | 47 | 0.150 |
Why?
| | Spin Labels | 2 | 2025 | 59 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2019 | 70 | 0.150 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 104 | 0.150 |
Why?
| | Blotting, Western | 5 | 2015 | 1207 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 39 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 71 | 0.150 |
Why?
| | Ferritins | 2 | 2010 | 69 | 0.150 |
Why?
| | Equipment and Supplies | 1 | 2019 | 34 | 0.150 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 330 | 0.150 |
Why?
| | Osmotic Fragility | 2 | 2024 | 12 | 0.150 |
Why?
| | Nitrates | 2 | 2020 | 100 | 0.150 |
Why?
| | Toxicokinetics | 1 | 2018 | 9 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 352 | 0.140 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 41 | 0.140 |
Why?
| | Female | 18 | 2026 | 78213 | 0.140 |
Why?
| | Erythropoietin | 2 | 2018 | 100 | 0.140 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2633 | 0.140 |
Why?
| | Antibodies | 1 | 2021 | 402 | 0.140 |
Why?
| | Cell Communication | 1 | 2020 | 326 | 0.140 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 188 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 685 | 0.140 |
Why?
| | Lipocalin-2 | 1 | 2018 | 79 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2018 | 158 | 0.140 |
Why?
| | Fibrin | 1 | 2019 | 91 | 0.140 |
Why?
| | Plasma | 1 | 2020 | 227 | 0.140 |
Why?
| | Liver Diseases | 1 | 2021 | 278 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 180 | 0.140 |
Why?
| | Metabolic Clearance Rate | 2 | 2012 | 116 | 0.140 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 331 | 0.130 |
Why?
| | Models, Cardiovascular | 1 | 2019 | 197 | 0.130 |
Why?
| | Neutrophil Activation | 1 | 2018 | 85 | 0.130 |
Why?
| | Hepcidins | 2 | 2015 | 22 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2018 | 992 | 0.130 |
Why?
| | Temperature | 1 | 2021 | 684 | 0.130 |
Why?
| | Physical Exertion | 1 | 2018 | 211 | 0.130 |
Why?
| | Serine Endopeptidases | 1 | 2018 | 128 | 0.130 |
Why?
| | Solutions | 2 | 2010 | 166 | 0.130 |
Why?
| | Oxymorphone | 1 | 2016 | 5 | 0.130 |
Why?
| | United States Food and Drug Administration | 1 | 2017 | 201 | 0.130 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 37 | 0.130 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 334 | 0.120 |
Why?
| | Dogs | 3 | 2022 | 438 | 0.120 |
Why?
| | Metabolomics | 4 | 2025 | 733 | 0.120 |
Why?
| | Proteins | 1 | 2023 | 1029 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2019 | 11581 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 639 | 0.120 |
Why?
| | Swine | 4 | 2021 | 843 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1829 | 0.120 |
Why?
| | Microcirculation | 2 | 2020 | 138 | 0.120 |
Why?
| | Sepsis | 2 | 2020 | 640 | 0.120 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2018 | 108 | 0.120 |
Why?
| | Cardiac Surgical Procedures | 1 | 2021 | 599 | 0.110 |
Why?
| | Spin Trapping | 1 | 2015 | 3 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 382 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 377 | 0.110 |
Why?
| | Heart | 1 | 2019 | 635 | 0.110 |
Why?
| | Disease Progression | 3 | 2023 | 2881 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 988 | 0.110 |
Why?
| | Protein Stability | 3 | 2012 | 180 | 0.110 |
Why?
| | Splenomegaly | 1 | 2015 | 13 | 0.110 |
Why?
| | Muscle Contraction | 1 | 2018 | 432 | 0.110 |
Why?
| | Procollagen-Proline Dioxygenase | 2 | 2011 | 27 | 0.110 |
Why?
| | Tissue Distribution | 2 | 2025 | 328 | 0.110 |
Why?
| | Cardiac Output | 2 | 2012 | 179 | 0.110 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 149 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 576 | 0.100 |
Why?
| | Prostatic Neoplasms | 1 | 2021 | 977 | 0.100 |
Why?
| | Altitude | 1 | 2018 | 474 | 0.100 |
Why?
| | Cell-Free System | 3 | 2011 | 53 | 0.100 |
Why?
| | Hemorrhage | 1 | 2019 | 801 | 0.100 |
Why?
| | Mesocricetus | 2 | 2026 | 46 | 0.100 |
Why?
| | Excipients | 2 | 2024 | 54 | 0.100 |
Why?
| | Endotoxemia | 1 | 2014 | 88 | 0.100 |
Why?
| | Adult | 6 | 2026 | 40438 | 0.100 |
Why?
| | Cross-Linking Reagents | 2 | 2012 | 208 | 0.100 |
Why?
| | Cricetinae | 2 | 2026 | 300 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2015 | 248 | 0.100 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 19 | 0.100 |
Why?
| | Creatinine | 2 | 2012 | 492 | 0.100 |
Why?
| | Models, Molecular | 3 | 2020 | 1603 | 0.090 |
Why?
| | Reactive Oxygen Species | 2 | 2007 | 649 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4253 | 0.090 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 33 | 0.090 |
Why?
| | Infusion Pumps | 1 | 2012 | 32 | 0.090 |
Why?
| | Macaca mulatta | 2 | 2025 | 191 | 0.090 |
Why?
| | Malaria | 1 | 2013 | 73 | 0.090 |
Why?
| | Membrane Proteins | 3 | 2020 | 1184 | 0.090 |
Why?
| | Exercise | 1 | 2024 | 2206 | 0.090 |
Why?
| | Cardio-Renal Syndrome | 1 | 2012 | 16 | 0.090 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2023 | 97 | 0.090 |
Why?
| | Neutrophils | 1 | 2018 | 1146 | 0.090 |
Why?
| | Transcriptome | 2 | 2018 | 1060 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1685 | 0.090 |
Why?
| | Dimerization | 2 | 2010 | 194 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 378 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 22 | 0.090 |
Why?
| | Glycolysis | 2 | 2025 | 342 | 0.090 |
Why?
| | Tyrosine | 1 | 2012 | 227 | 0.090 |
Why?
| | Occludin | 1 | 2011 | 12 | 0.090 |
Why?
| | Cohort Studies | 2 | 2021 | 5898 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2011 | 17 | 0.090 |
Why?
| | Cytokines | 2 | 2021 | 2100 | 0.090 |
Why?
| | Iron Chelating Agents | 1 | 2011 | 18 | 0.090 |
Why?
| | Surface Plasmon Resonance | 2 | 2008 | 91 | 0.090 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 86 | 0.090 |
Why?
| | Area Under Curve | 1 | 2012 | 334 | 0.090 |
Why?
| | Claudins | 1 | 2011 | 24 | 0.090 |
Why?
| | Basilar Artery | 2 | 2021 | 6 | 0.080 |
Why?
| | Heart Diseases | 1 | 2014 | 343 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3628 | 0.080 |
Why?
| | Erythrocyte Aggregation | 1 | 2010 | 4 | 0.080 |
Why?
| | Filtration | 1 | 2010 | 70 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1517 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 155 | 0.080 |
Why?
| | Biophysics | 1 | 2010 | 75 | 0.080 |
Why?
| | Pyridones | 1 | 2011 | 200 | 0.070 |
Why?
| | Fatty Acids | 2 | 2023 | 451 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2024 | 726 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 404 | 0.070 |
Why?
| | Aorta | 1 | 2012 | 432 | 0.070 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2008 | 9 | 0.070 |
Why?
| | Pneumonia | 1 | 2015 | 642 | 0.070 |
Why?
| | Globins | 1 | 2008 | 21 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2011 | 348 | 0.070 |
Why?
| | alpha-Globins | 1 | 2008 | 9 | 0.070 |
Why?
| | Cellular Senescence | 1 | 2011 | 229 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2015 | 4177 | 0.070 |
Why?
| | Buffers | 1 | 2008 | 56 | 0.070 |
Why?
| | Hemin | 2 | 2021 | 4 | 0.070 |
Why?
| | Lasers | 2 | 2005 | 132 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2017 | 451 | 0.070 |
Why?
| | Ferric Compounds | 1 | 2008 | 55 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2025 | 2196 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 209 | 0.070 |
Why?
| | Drug Stability | 1 | 2007 | 165 | 0.060 |
Why?
| | Tissue Engineering | 1 | 2011 | 446 | 0.060 |
Why?
| | Binding Sites | 2 | 2011 | 1314 | 0.060 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 499 | 0.060 |
Why?
| | Cell Tracking | 1 | 2026 | 19 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 163 | 0.060 |
Why?
| | Pentetic Acid | 1 | 2005 | 13 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2018 | 346 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 569 | 0.060 |
Why?
| | Molecular Structure | 1 | 2007 | 499 | 0.060 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 119 | 0.060 |
Why?
| | Raffinose | 1 | 2005 | 29 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 454 | 0.060 |
Why?
| | Cystine | 1 | 2005 | 18 | 0.060 |
Why?
| | Cysteine | 1 | 2006 | 211 | 0.060 |
Why?
| | Coronary Vessels | 2 | 2018 | 250 | 0.060 |
Why?
| | Scattering, Radiation | 1 | 2005 | 102 | 0.060 |
Why?
| | Child | 2 | 2023 | 22620 | 0.050 |
Why?
| | Time Factors | 2 | 2015 | 7107 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2517 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | Kinetics | 1 | 2008 | 1627 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2021 | 752 | 0.050 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2024 | 9 | 0.050 |
Why?
| | Peptides | 1 | 2010 | 1002 | 0.050 |
Why?
| | Chlorides | 1 | 2005 | 138 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2017 | 2543 | 0.050 |
Why?
| | Phenotype | 2 | 2026 | 3199 | 0.050 |
Why?
| | Aerosols | 1 | 2025 | 185 | 0.050 |
Why?
| | Fish Oils | 1 | 2023 | 26 | 0.050 |
Why?
| | Particle Size | 1 | 2005 | 409 | 0.050 |
Why?
| | Acute Disease | 2 | 2021 | 1006 | 0.050 |
Why?
| | Models, Chemical | 1 | 2004 | 270 | 0.050 |
Why?
| | Heart Rate | 1 | 2007 | 847 | 0.050 |
Why?
| | Allografts | 1 | 2024 | 151 | 0.050 |
Why?
| | Ventricular Function, Right | 1 | 2025 | 297 | 0.050 |
Why?
| | Piperidines | 1 | 2004 | 219 | 0.050 |
Why?
| | Cercopithecidae | 1 | 2002 | 8 | 0.050 |
Why?
| | Risk Assessment | 1 | 2012 | 3580 | 0.050 |
Why?
| | Regional Blood Flow | 1 | 2004 | 509 | 0.050 |
Why?
| | Drug Compounding | 1 | 2022 | 106 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2024 | 1057 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2022 | 170 | 0.050 |
Why?
| | Hand | 1 | 2023 | 161 | 0.050 |
Why?
| | Protein Conformation | 1 | 2005 | 943 | 0.040 |
Why?
| | Biological Availability | 1 | 2002 | 141 | 0.040 |
Why?
| | Serum Albumin, Human | 1 | 2021 | 7 | 0.040 |
Why?
| | Young Adult | 1 | 2018 | 14028 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2022 | 104 | 0.040 |
Why?
| | Horses | 1 | 2022 | 204 | 0.040 |
Why?
| | Platelet Activation | 1 | 2022 | 103 | 0.040 |
Why?
| | Cell Survival | 2 | 2018 | 1113 | 0.040 |
Why?
| | Etanercept | 1 | 2021 | 60 | 0.040 |
Why?
| | Nitrites | 2 | 2013 | 89 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 53 | 0.040 |
Why?
| | Carnitine | 1 | 2021 | 89 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 977 | 0.040 |
Why?
| | Triage | 1 | 2023 | 247 | 0.040 |
Why?
| | ADAMTS13 Protein | 1 | 2020 | 7 | 0.040 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 243 | 0.040 |
Why?
| | Kynurenine | 1 | 2021 | 113 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 292 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 580 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 544 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1987 | 0.040 |
Why?
| | Tryptophan | 1 | 2021 | 180 | 0.040 |
Why?
| | von Willebrand Factor | 1 | 2020 | 85 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 35939 | 0.040 |
Why?
| | Administration, Oral | 1 | 2002 | 844 | 0.040 |
Why?
| | Cardiopulmonary Bypass | 1 | 2021 | 220 | 0.040 |
Why?
| | Blood Banks | 1 | 2019 | 50 | 0.040 |
Why?
| | Blood Donors | 1 | 2021 | 143 | 0.040 |
Why?
| | Lactic Acid | 1 | 2021 | 305 | 0.040 |
Why?
| | Cerebrospinal Fluid | 1 | 2019 | 92 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2019 | 62 | 0.040 |
Why?
| | Organ Culture Techniques | 1 | 2019 | 153 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 86 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 192 | 0.040 |
Why?
| | Transfection | 1 | 2021 | 952 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 593 | 0.040 |
Why?
| | Intracranial Aneurysm | 1 | 2019 | 101 | 0.040 |
Why?
| | Endothelins | 1 | 2018 | 64 | 0.030 |
Why?
| | Blood Platelets | 1 | 2022 | 398 | 0.030 |
Why?
| | Tissue Donors | 1 | 2021 | 423 | 0.030 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 245 | 0.030 |
Why?
| | Blood Safety | 1 | 2017 | 11 | 0.030 |
Why?
| | Hemodilution | 2 | 2008 | 11 | 0.030 |
Why?
| | Vasodilation | 1 | 2021 | 521 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 512 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2018 | 77 | 0.030 |
Why?
| | Viscosity | 1 | 2018 | 91 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 285 | 0.030 |
Why?
| | Precision Medicine | 1 | 2022 | 463 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 16 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 858 | 0.030 |
Why?
| | Metabolome | 1 | 2020 | 388 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2015 | 2149 | 0.030 |
Why?
| | Sheep | 1 | 2019 | 874 | 0.030 |
Why?
| | Acclimatization | 1 | 2018 | 172 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1741 | 0.030 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 2006 | 19 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 577 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1058 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1870 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2016 | 183 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 588 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 2030 | 0.030 |
Why?
| | Electric Impedance | 1 | 2015 | 113 | 0.030 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 79 | 0.030 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2015 | 98 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2019 | 754 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 364 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 586 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2860 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 427 | 0.030 |
Why?
| | Apoptosis | 2 | 2014 | 2454 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 388 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2940 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2013 | 114 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2448 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2017 | 791 | 0.020 |
Why?
| | Mitochondria | 1 | 2019 | 988 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 167 | 0.020 |
Why?
| | Phagocytosis | 1 | 2014 | 303 | 0.020 |
Why?
| | Iron Metabolism Disorders | 1 | 2011 | 6 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 21 | 0.020 |
Why?
| | Deferoxamine | 1 | 2011 | 25 | 0.020 |
Why?
| | Siderophores | 1 | 2011 | 12 | 0.020 |
Why?
| | Hydroxylation | 1 | 2011 | 48 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2011 | 116 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1701 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 87 | 0.020 |
Why?
| | Cobalt | 1 | 2011 | 53 | 0.020 |
Why?
| | DNA Damage | 1 | 2014 | 436 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 674 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 564 | 0.020 |
Why?
| | Bioreactors | 1 | 2011 | 50 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 362 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2914 | 0.020 |
Why?
| | Tight Junctions | 1 | 2011 | 81 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 121 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 875 | 0.020 |
Why?
| | Hemoglobinuria | 1 | 2010 | 5 | 0.020 |
Why?
| | Glucose Oxidase | 1 | 2010 | 25 | 0.020 |
Why?
| | Caspase 3 | 1 | 2011 | 242 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2010 | 203 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3147 | 0.020 |
Why?
| | Nitroso Compounds | 1 | 2009 | 7 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2009 | 21 | 0.020 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 103 | 0.020 |
Why?
| | Astrocytes | 1 | 2011 | 223 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7947 | 0.020 |
Why?
| | Canada | 1 | 2010 | 425 | 0.020 |
Why?
| | Glutathione | 1 | 2010 | 379 | 0.020 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 265 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 240 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 766 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 247 | 0.020 |
Why?
| | Heart Failure | 1 | 2021 | 2181 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2934 | 0.020 |
Why?
| | Peroxides | 1 | 2006 | 19 | 0.020 |
Why?
| | Erythrocyte Membrane | 1 | 2006 | 55 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 899 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2005 | 15 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2005 | 39 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 657 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2009 | 540 | 0.010 |
Why?
| | Endocytosis | 1 | 2005 | 171 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 379 | 0.010 |
Why?
| | Endosomes | 1 | 2005 | 143 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1506 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 706 | 0.010 |
Why?
| | United States | 1 | 2017 | 15720 | 0.010 |
Why?
|
|
Buehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|